Article
Comparative characterization of transfection- and infection-derived simian immunodeficiency virus challenge stocks for in vivo nonhuman primate studies.
Journal of virology - 1 Apr 2013
Del Prete Gregory Q, Scarlotta Matthew, Newman Laura, Reid Carolyn, Parodi Laura M, Roser James D, Oswald Kelli, Marx Preston A, Miller Christopher J, Desrosiers Ronald C, Barouch Dan H, Pal Ranajit, Piatak Michael, Chertova Elena, Giavedoni Luis D, O'Connor David H, Lifson Jeffrey D, Keele Brandon F
Abstract excerpt
Simian immunodeficiency virus (SIV) stocks for in vivo nonhuman primate models of AIDS are typically generated by transfection of 293T cells with molecularly cloned viral genomes or by expansion in productively infected T cells. Although titers of stocks are determined for infectivity in vitro prior to in vivo inoculation, virus production methods may differentially affect stock features that are not routinely...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
